Virtual Tour
Media
NEWS
Contact Us
Patients
Neurology & Ophthalmology
CinnoVex
ReciGen
CinnoTec
Xacrel
TYALIa
Cinnomer
Oncology & Hematology
PegaGen
CinnaPoietin
ZakAria
Ablyze
CinnaStim
Pectuna
Xtramab
KidiPeg
Endocrinology & infertility
Cinnal-f
CinnaFact
CinnaTropin
Melitide
CinnoPar
Maciza
Lixafert
Herozyme
Autoimmune & Immunology & Enzymes
Zerafil
SpikoGen
Eldixia
CinnoRA
Healthcare Professionals
Neurology & Ophthalmology
CinnoVex
ReciGen
Cinnomer
Xacrel
TYALIa
CinnoTec
Oncology & Hematology
PegaGen
CinnaPoietin
KidiPeg
ZakAria
Ablyze
CinnaStim
Pectuna
Endocrinology & infertility
Cinnal-f
CinnaTropin
CinnaFact
CinnoPar
Herozyme
Melitide
Autoimmune & Immunology
CinnoRA
Zerafil
SpikoGen
Capabilities
Our Technology
Business Development
Our Manufacturing Sites
Research and Development
About Us
Presidential Note
About CinnaGen
Mission Statement
Policy
Management Team
Search
Virtual Tour
Media
NEWS
Contact Us
CinnoRA
A new present from CinnaGen to patients who are suffering from rheumatoid arthritis.
A new present from CinnaGen to patients who are suffering from rheumatoid arthritis.
Sept.2016 / Public Relations Department / CinnaGen
Previuos News
Liquid CinnoVex is now available in the market
Next News
Cooperation between CYPRUS and IRAN in health sector
tags:
Rheumatoid Arthritis
CinnoRA
Adalimumab
More in this category:
CinnoRA®
Launching the Iranian medicine "CinnoRA", in the presence of Minister of Health
26Oct 2016
Home
CinnoRA is now available in the market
Back top Top
